FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993997002> ?p ?o ?g. }

• W1993997002 endingPage "665" @default.
• W1993997002 startingPage "657" @default.
• W1993997002 abstract "Study Objectives. To evaluate the efficacy of a single, low-dose injection of botulinum toxin type A in relieving pain in Korean patients with piriformis syndrome resistant to conventional therapy, and to assess the drug's influence on these patients' quality of life. Design. Prospective, single-site, open-label trial. Setting. Rehabilitation medicine clinic in Seoul, Korea. Patients. Twenty-nine patients with a confirmed diagnosis of chronic piriformis syndrome and 82 age- and sex-matched healthy subjects were enrolled from April 1, 2003–February 28, 2004. Intervention. In 20 of the patients, botulinum toxin type A 150 U was injected using computed tomographic guidance into the affected unilateral piriformis muscle. The other nine patients served as active controls and received an injection of dexamethasone 5 mg and 1% lidocaine. The healthy subjects did not receive any injection. Measurements and Main Results. The patients' pain at baseline and at 4, 8, and 12 weeks after treatment was rated by using a numeric rating scale. Health-related quality of life was assessed by using the validated Korean version of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) at baseline and at 4 weeks of treatment. Healthy subjects also completed the SF-36 at baseline. Pain intensity scores were significantly lower at 4, 8, and 12 weeks after treatment than at baseline (p<0.0001). Baseline scores from the SF-36 subscales, including those for physical functioning (p<0.0001), role physical (p<0.0001), bodily pain (p<0.0001), general health (p<0.0001), vitality (p<0.0001), and social functioning (p<0.002), were significantly lower in the patients than in the healthy subjects. Four weeks after treatment, physical functioning (p=0.003), role physical (p=0.021), bodily pain (p=0.016), general health (p=0.013), vitality (p=0.031) and social functioning (p=0.035) improved significantly from baseline in the patients. However, at 4 weeks, patients in the active control group were withdrawn from the study because their pain did not improve, and continuation without further medical care was considered unethical. Conclusion. A low dose of botulinum toxin type A relieved pain and improved quality of life in patients with refractory piriformis syndrome." @default.
• W1993997002 created "2016-06-24" @default.
• W1993997002 creator A5009725517 @default.
• W1993997002 creator A5039274339 @default.
• W1993997002 creator A5044392908 @default.
• W1993997002 creator A5063812803 @default.
• W1993997002 creator A5064765332 @default.
• W1993997002 creator A5067669357 @default.
• W1993997002 creator A5090614822 @default.
• W1993997002 date "2007-05-01" @default.
• W1993997002 modified "2023-09-27" @default.
• W1993997002 title "Low-Dose Botulinum Toxin Type A for the Treatment of Refractory Piriformis Syndrome" @default.
• W1993997002 cites W1606564954 @default.
• W1993997002 cites W1975770638 @default.
• W1993997002 cites W1990353610 @default.
• W1993997002 cites W1996085111 @default.
• W1993997002 cites W1997686340 @default.
• W1993997002 cites W1998356374 @default.
• W1993997002 cites W2004994969 @default.
• W1993997002 cites W2005400423 @default.
• W1993997002 cites W2014217746 @default.
• W1993997002 cites W2021575173 @default.
• W1993997002 cites W2022213939 @default.
• W1993997002 cites W2028240148 @default.
• W1993997002 cites W2038356394 @default.
• W1993997002 cites W2042826077 @default.
• W1993997002 cites W2059076593 @default.
• W1993997002 cites W2059297999 @default.
• W1993997002 cites W2061700557 @default.
• W1993997002 cites W2076056141 @default.
• W1993997002 cites W2077298856 @default.
• W1993997002 cites W2082127529 @default.
• W1993997002 cites W2094515494 @default.
• W1993997002 cites W2107169648 @default.
• W1993997002 cites W2111095903 @default.
• W1993997002 cites W2135481384 @default.
• W1993997002 cites W2158385759 @default.
• W1993997002 cites W2158718658 @default.
• W1993997002 cites W2161390592 @default.
• W1993997002 cites W2317980980 @default.
• W1993997002 cites W32896427 @default.
• W1993997002 cites W4210997568 @default.
• W1993997002 doi "https://doi.org/10.1592/phco.27.5.657" @default.
• W1993997002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17461700" @default.
• W1993997002 hasPublicationYear "2007" @default.
• W1993997002 type Work @default.
• W1993997002 sameAs 1993997002 @default.
• W1993997002 citedByCount "63" @default.
• W1993997002 countsByYear W19939970022012 @default.
• W1993997002 countsByYear W19939970022013 @default.
• W1993997002 countsByYear W19939970022014 @default.
• W1993997002 countsByYear W19939970022015 @default.
• W1993997002 countsByYear W19939970022016 @default.
• W1993997002 countsByYear W19939970022017 @default.
• W1993997002 countsByYear W19939970022018 @default.
• W1993997002 countsByYear W19939970022019 @default.
• W1993997002 countsByYear W19939970022020 @default.
• W1993997002 countsByYear W19939970022021 @default.
• W1993997002 countsByYear W19939970022022 @default.
• W1993997002 countsByYear W19939970022023 @default.
• W1993997002 crossrefType "journal-article" @default.
• W1993997002 hasAuthorship W1993997002A5009725517 @default.
• W1993997002 hasAuthorship W1993997002A5039274339 @default.
• W1993997002 hasAuthorship W1993997002A5044392908 @default.
• W1993997002 hasAuthorship W1993997002A5063812803 @default.
• W1993997002 hasAuthorship W1993997002A5064765332 @default.
• W1993997002 hasAuthorship W1993997002A5067669357 @default.
• W1993997002 hasAuthorship W1993997002A5090614822 @default.
• W1993997002 hasBestOaLocation W19939970021 @default.
• W1993997002 hasConcept C121332964 @default.
• W1993997002 hasConcept C126322002 @default.
• W1993997002 hasConcept C142424586 @default.
• W1993997002 hasConcept C159110408 @default.
• W1993997002 hasConcept C1862650 @default.
• W1993997002 hasConcept C188816634 @default.
• W1993997002 hasConcept C2776698514 @default.
• W1993997002 hasConcept C2777478456 @default.
• W1993997002 hasConcept C2779453535 @default.
• W1993997002 hasConcept C2779951463 @default.
• W1993997002 hasConcept C2780149897 @default.
• W1993997002 hasConcept C42219234 @default.
• W1993997002 hasConcept C71924100 @default.
• W1993997002 hasConcept C87355193 @default.
• W1993997002 hasConceptScore W1993997002C121332964 @default.
• W1993997002 hasConceptScore W1993997002C126322002 @default.
• W1993997002 hasConceptScore W1993997002C142424586 @default.
• W1993997002 hasConceptScore W1993997002C159110408 @default.
• W1993997002 hasConceptScore W1993997002C1862650 @default.
• W1993997002 hasConceptScore W1993997002C188816634 @default.
• W1993997002 hasConceptScore W1993997002C2776698514 @default.
• W1993997002 hasConceptScore W1993997002C2777478456 @default.
• W1993997002 hasConceptScore W1993997002C2779453535 @default.
• W1993997002 hasConceptScore W1993997002C2779951463 @default.
• W1993997002 hasConceptScore W1993997002C2780149897 @default.
• W1993997002 hasConceptScore W1993997002C42219234 @default.
• W1993997002 hasConceptScore W1993997002C71924100 @default.
• W1993997002 hasConceptScore W1993997002C87355193 @default.
• W1993997002 hasIssue "5" @default.

• next